KRISTENSEN, Steen D., Kristina G. LAUT, Jean FAJADET, Zuzana KAIFOSZOVA, Petr KALA, Mario Di CARLO, William WIJNS, Peter CLEMMENSEN, Vaja AGLADZE, Loizos ANTONIADES, Khalid F. ALHABIB, Menko-Jan De BOER, MarcJ. CLAEYS, Dan DELEANU, Dariusz DUDEK, Andrejs ERGLIS, Martine GILARD, Omer GOKTEKIN, Giulio GUAGLIUMI, Thorarinn GUDNASON, Kim Wadt HANSEN, Kurt HUBER, Stefan JAMES, Tomáš JANOTA, Siobhan JENNINGS, Olli KAJANDER, John KANAKAKIS, Kiril K. KARAMFILOFF, Sasko KEDEV, Ran KORNOWSKI, Peter F. LUDMAN, Béla MERKELY, Davor MILICIC, Ruslan NAJAFOV, Francesca A. NICOLINI, Marko NOČ, Miodrag OSTOJIC, Hélder PEREIRA, Dragana RADOVANOVIC, Manel SABATÉ, Mohamed SOBHY, Maxim SOKOLOV, Martin STUDENCAN, Ibrahim TERZIC, Steffen WAHLER a Petr WIDIMSKY. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. European heart journal. Oxford: Oxford University Press, 2014, roč. 35, č. 29, s. 1957-1970. ISSN 0195-668X. Dostupné z: https://dx.doi.org/10.1093/eurheartj/eht529.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries
Autoři KRISTENSEN, Steen D. (208 Dánsko), Kristina G. LAUT (208 Dánsko), Jean FAJADET (250 Francie), Zuzana KAIFOSZOVA (826 Velká Británie a Severní Irsko), Petr KALA (203 Česká republika, garant, domácí), Mario Di CARLO (826 Velká Británie a Severní Irsko), William WIJNS (56 Belgie), Peter CLEMMENSEN (208 Dánsko), Vaja AGLADZE (268 Gruzie), Loizos ANTONIADES (196 Kypr), Khalid F. ALHABIB (682 Saúdská Arábie), Menko-Jan De BOER (528 Nizozemské království), MarcJ. CLAEYS (56 Belgie), Dan DELEANU (642 Rumunsko), Dariusz DUDEK (616 Polsko), Andrejs ERGLIS (440 Litva), Martine GILARD (250 Francie), Omer GOKTEKIN (792 Turecko), Giulio GUAGLIUMI (380 Itálie), Thorarinn GUDNASON (372 Irsko), Kim Wadt HANSEN (208 Dánsko), Kurt HUBER (40 Rakousko), Stefan JAMES (752 Švédsko), Tomáš JANOTA (203 Česká republika), Siobhan JENNINGS (372 Irsko), Olli KAJANDER (246 Finsko), John KANAKAKIS (300 Řecko), Kiril K. KARAMFILOFF (100 Bulharsko), Sasko KEDEV (807 Severní Makedonie), Ran KORNOWSKI (376 Izrael), Peter F. LUDMAN (826 Velká Británie a Severní Irsko), Béla MERKELY (348 Maďarsko), Davor MILICIC (191 Chorvatsko), Ruslan NAJAFOV (31 Ázerbájdžán), Francesca A. NICOLINI (674 San Marino), Marko NOČ (705 Slovinsko), Miodrag OSTOJIC (688 Srbsko), Hélder PEREIRA (620 Portugalsko), Dragana RADOVANOVIC (756 Švýcarsko), Manel SABATÉ (724 Španělsko), Mohamed SOBHY (818 Egypt), Maxim SOKOLOV (804 Ukrajina), Martin STUDENCAN (703 Slovensko), Ibrahim TERZIC (70 Bosna a Hercegovina), Steffen WAHLER (276 Německo) a Petr WIDIMSKY (203 Česká republika).
Vydání European heart journal, Oxford, Oxford University Press, 2014, 0195-668X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 15.203
Kód RIV RIV/00216224:14110/14:00075579
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1093/eurheartj/eht529
UT WoS 000342232100010
Klíčová slova anglicky Primary percutaneous coronary intervention; STEMI; Treatment variation; Europe
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 23. 10. 2014 14:01.
Anotace
Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.
VytisknoutZobrazeno: 25. 4. 2024 11:49